Spero Therap (SPRO.US) Latest Stock News - Major News Analysis

Event Tracking

Nov14

Spero Therap released FY2025 Q3 earnings on November 13 After-Market EST, with actual revenue of USD 5.442 M (forecast USD 0) and actual EPS of USD -0.1311 (forecast USD -0.25)

00:00

Spero Therap released FY2025 9 Months earnings on November 13 After-Market (EST), actual revenue USD 25.51 M, actual EPS USD -0.4119

00:00

Nov6

Spero Therapeutics to Release FY2025 Q3 Earnings on November 13 After-Market (EST), Forecast EPS -0.25 USD

00:25

Oct21

Spero Therapeutics and GSK Announce Positive Results for tebipenem HBr Phase III Trial

06:00

Aug12

Spero Therap released FY2025 Semi-Annual Earnings on August 12 After-Market (EST), Actual Revenue: USD 20.06M, Actual EPS: USD -0.2794

23:00

Spero Therap released FY2025 Q2 earnings on August 12 After-Market EST: Actual Revenue USD 14.19 M (Forecast USD 0), Actual EPS USD -0.0303 (Forecast USD -0.38)

23:00